DocSym
β
Searchsearch
Search
(D59.2) Drug-induced nonautoimmune haemolytic anaemia
More details coming soon
334 581 in individuals diagnosis drug-induced nonautoimmune haemolytic anaemia confirmed
11 068 deaths with diagnosis drug-induced nonautoimmune haemolytic anaemia
3% mortality rate associated with the disease drug-induced nonautoimmune haemolytic anaemia
Diagnosis drug-induced nonautoimmune haemolytic anaemia is diagnosed Women are 8.82% more likely than Men
152 537
Men receive the diagnosis drug-induced nonautoimmune haemolytic anaemia
4 524 (3.0 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
182 044
Women receive the diagnosis drug-induced nonautoimmune haemolytic anaemia
6 544 (3.6 %)Died from this diagnosis.
Risk Group for the Disease drug-induced nonautoimmune haemolytic anaemia - Men aged 0-5 and Women aged 75-79
In Men diagnosis is most often set at age 0-94
Less common in men the disease occurs at Age 95+in in women, the disease manifests at any age
In Women diagnosis is most often set at age 0-95+
Disease Features drug-induced nonautoimmune haemolytic anaemia
Absence or low individual and public risk
Drug-induced nonautoimmune haemolytic anaemia - what does this mean
Drug-induced nonautoimmune haemolytic anaemia is caused by the direct toxicity of certain drugs and chemicals on the red blood cells, leading to their destruction and subsequent anemia. the drugs that are known to cause this type of anemia include antibiotics, anticonvulsants, chemotherapeutic agents, and non-steroidal anti-inflammatory drugs.
What happens during the disease - drug-induced nonautoimmune haemolytic anaemia
Drug-induced nonautoimmune haemolytic anaemia is caused by the direct toxic effect of drugs on the red blood cells. the drugs can cause oxidative damage to the cell membrane, leading to increased fragility and subsequent destruction of the red blood cells in the spleen and other organs. in addition, some drugs can inhibit the enzymes responsible for the production of red blood cells, leading to a decrease in the number of red blood cells in circulation.
Clinical Pattern
More details coming soon
How does a doctor diagnose
More details coming soon
Treatment and Medical Assistance
More details coming soon
17 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Drug-induced nonautoimmune haemolytic anaemia - Prevention
Drug-induced nonautoimmune haemolytic anaemia can be prevented by avoiding the use of known haemolytic drugs, monitoring and adjusting the dose of drugs that may cause haemolytic reactions, and avoiding the use of drugs that are known to interact with other drugs that may cause haemolytic reactions.